XIAP and survivin as therapeutic target's for radiation sensitization in preclinical models of lung cancer

Carolyn Cao, Yi Mu, Dennis E. Hallahan, Bo Lu

Research output: Contribution to journalArticlepeer-review

149 Scopus citations

Abstract

Survivin and XIAP are members of inhibitors of apoptosis (IAPs) family. They are upregulated in various malignancies. Inactivation of these molecules has resulted in chemosensitization. The purpose of this study was to determine whether inhibition of survivin, XIAP, or both enhances radiotherapy in a lung cancer model. Transient transfection of H460 cells with antisense oligonucleotides (ASOs) against either molecule has specifically reduced their expression, by Western analysis. Results from 3-(4,5-methyltniazol-2-yl)-2,5- dipfaenyl-tetrazolium bromide and clonogenic assays suggest that inhibition of survivin or XIAP greatly decreased cell survival following irradiation. A significantly increased number of apoptotic cells were detected when H460 cells were treated with either antisurvivin, anti-XIAP or both ASOs (P = 0.03, 0.0003 and 0.01, respectively) plus irradiation. H460 xenografts that were treated with ASOs plus radiotherapy demonstrated growth delay beyond 15 days. Growth delay in the groups of combined treatment was greater than that in other groups. However, treatment with ASOs alone did not affect tumor growth delay in mice, but decreased the survival of H460 cells in culture. Antisense treatment did not cause any mortality or weight loss during the 32 days of study. These data suggest that inhibition of survivin or XIAP radiosensitizes H460 lung cancer cells by upregulating apoptosis and downregulating cell survival. Combination of radiotherapy and inhibition of survivin and XIAP through the antisense approach results in improved tumor control by radiotherapy in a mouse model of lung cancer.

Original languageEnglish
Pages (from-to)7047-7052
Number of pages6
JournalOncogene
Volume23
Issue number42
DOIs
StatePublished - Sep 16 2004

Keywords

  • Lung cancer
  • Radio therapy
  • Survivin
  • XIAP

Fingerprint

Dive into the research topics of 'XIAP and survivin as therapeutic target's for radiation sensitization in preclinical models of lung cancer'. Together they form a unique fingerprint.

Cite this